Archive for February, 2007
UCLA & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients
The University of California at Los Angeles & SiliconMED announced today the launch of ProbeSetAnalyzer.com, a new web based tool aiming to help clinicians better visualize gene expression levels and how they relate to the overall survival of brain cancer patients. (PRWeb Feb 26, 2007)
Post Comment:Trackback URL: http://www.prweb.com/dingpr.php/Q3Jhcy1Ib3JyLVN1bW0tSG9yci1NYWduLVplcm8=
Successful Soul Transplant Operation Featured in New Sci-Fi Book, Last call from Earth
Soul transplant operation is the last recourse for human survival in new trilogy, “Last call from Earth” — people affected with CRDS lose their DNA controls and become repugnant. The body becomes an uncontrollable mess. There is no cure for CRDS. The only solution is to transplant the souls to healthy bodies. (PRWeb Feb 22, 2007)
Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/UHJvZi1Qcm9mLVRoaXItSG9yci1NYWduLVplcm8=
Changing the Diagnostics Paradigm: Oxford NanoLabs’ Next-Generation Analytical System Will Bring the Genetic Revolution to Modern Healthcare
Oxford NanoLabs’ nanopore-based platform that offers rapid, early, cost-effective, highly sensitive, and accurate diagnosis at the point-of-care will be discussed by Dr. Spike WIllcocks in the Partnering Showcase of the Molecular Medicine Conference 2/27/07 in San Francisco. Oxford NanoLabs (ONL) currently has in development both a rapid influenza test and a blood-based Alzheimer’s diagnostic. ONL’s longer-term goal is to achieve $1,000 human-genome sequencing. (PRWeb Feb 21, 2007)
Post Comment:Trackback URL: http://www.prweb.com/zingpr.php/Q291cC1TcXVhLUhvcnItSG9yci1NYWduLVplcm8=
Genome Synthesis and Design Futures: Implications for the U.S. Economy
Bio-era releases new report analyzing economic implications of rapid advances in gene sequencing and synthesis technologies — big changes coming for energy, chemicals, and vaccine production. (PRWeb Feb 21, 2007)
Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/UHJvZi1IYWxmLUVtcHQtSG9yci1NYWduLVplcm8=
New Tools Developed by Vitalea Science for Pediatric Pharmacology Use Microdose and Accelerator Mass Spectrometry
Vitalea Science announces the development and testing of assays to quantify intracellular uptake and DNA incorporation of the active metabolite of an anti-HIV drug that can be applied to children and neonates. (PRWeb Feb 15, 2007)
Post Comment:Trackback URL: http://www.prweb.com/zingpr.php/SGFsZi1FbXB0LUhhbGYtSG9yci1NYWduLVplcm8=
Applied Biosystems Introduces New DNA Technologies that Address Major Challenges Facing Forensic Scientists: New Tools Focus on Analysis of Degraded Samples, Laboratory Automation and Validation
Applied Biosystems (NYSE: ABI), an Applera Corporation business, today announced the first commercial reagent kit for analyzing degraded or limited DNA; a system with new software for automating DNA testing processes to streamline forensic laboratory workflow; and a new software application for expediting the process of laboratory validation. The company said that it expects the AmpFLSTR(R) MiniFiler(TM) PCR Amplification Kit for degraded DNA, the HID EVOlution(TM) System and VALID(TM) Software will help the more than 10,000 forensic laboratories around the world maximize the use of DNA in human identification. (PRWeb Feb 14, 2007)
Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/U3VtbS1DcmFzLVBpZ2ctSG9yci1NYWduLVplcm8=
Applied Biosystems Advances Forensic Science with the World’s First Commercial Chemistry for Analyzing Degraded DNA: AmpFLSTR(R) MiniFiler(TM) PCR Amplification Kit increasesusability of compromised samples in criminal investigations andmissing pe
Applied Biosystems (NYSE: ABI), an Applera Corporation business, today announced the world’s first commercially available reagent kit for generating genetic profiles from aged, compromised, or damaged DNA samples. The new AmpFLSTR(R) MiniFiler(TM) PCR Amplification Kit was developed in response to the growing backlog of samples recovered from crime scene investigations and other instances of DNA collection in which the samples could not previously be identified because of poor sample quantity or quality. The new kit is expected to enable an increase in the number of solved criminal cases, in addition to aiding in the investigation of missing person occurrences. (PRWeb Feb 14, 2007)
Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/SG9yci1DcmFzLVBpZ2ctSG9yci1NYWduLVplcm8=
”African Gene” Found
GenoMed(R) (OTC Pink Sheets GMED), a Next Generation Disease Management company, announced today that it has found the “African gene,” responsible for the much higher incidence of diabetes, high blood pressure, and kidney failure among people of African ancestry than whites. (PRWeb Feb 13, 2007)
Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/VGhpci1DcmFzLUNvdXAtSG9yci1NYWduLVplcm8=
New Company Offers Comprehensive Child ID Kits
Child Safety Sense introduces an at-home ID collection and storage kit complete with fingerprinting and DNA. (PRWeb Feb 7, 2007)